VTVT Insider Trading Activity and SEC Form 4 Filings
VTVT insider trading summary
No open-market insider purchases or sales of vTv Therapeutics Inc. (VTVT) have been reported on SEC Form 4 in the past 12 months.
Latest VTVT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 18, 2024 | Paul J Sekhri | Pres, CEO and Exec Chairperson | Buy | $31K (1,844 @ $16.96) |
| Nov 15, 2024 | Paul J Sekhri | Pres, CEO and Exec Chairperson | Buy | $30K (1,778 @ $16.88) |
| Nov 15, 2024 | Paul J Sekhri | Pres, CEO and Exec Chairperson | Buy | $23K (1,378 @ $16.35) |
| Nov 29, 2022 | John A Fry | Director | Buy | $34K (40,461 @ $0.83) |
| Nov 28, 2022 | John A Fry | Director | Buy | $17K (20,539 @ $0.83) |
| Dec 20, 2021 | Ronald O Perelman | 10% Owner | Sell | $100K (87,000 @ $1.15) |
| Feb 26, 2021 | Hersh Kozlov | Insider | Buy | $27K (10,000 @ $2.74) |
| Feb 26, 2021 | Rich S. Nelson | Insider | Buy | $29K (10,000 @ $2.86) |
| Feb 26, 2021 | Rich S. Nelson | Insider | Buy | $143K (50,000 @ $2.86) |
| Dec 17, 2020 | Ronald O Perelman | Insider | Buy | $1.0M (625,000 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.